Asia-Pacific Single Cell Analysis Market Forecast 2017-2025

Asia-Pacific Single Cell Analysis Market Forecast 2017-2025

  • June 2017 •
  • Report ID: 4944904 •
  • Format: PDF
KEY FINDINGS
Asia-Pacific Single cell analysis market is estimated to grow at a CAGR of 20.12 % for the forecast year of 2017-2025 and is anticipated to generate a revenue of about $1530 million by the year 2025. Asia Pacific is anticipated to be the fastest growing market during the forecast period because of the increasing technological advancement and booming biotechnology and biopharmaceutical industries.


MARKET INSIGHTS
The Asia-Pacific market geography consists of countries like India, China, Australia, Japan and the Rest of Asia Pacific. The market potential in the Asia-Pacific region is mainly a result of a developing need for stem cell therapies for the treatment owing to increasing number of patient population and prevalence of chronic lifestyle diseases. An increase in the government funding for research, rising potential in single-cell DNA and RNA analysis and increasing occurrence of infectious diseases are the major factors contributing to the growth of the market.



COMPETITIVE INSIGHTS
The major players in the Single-cell analysis market are Thermo Fisher Scientific Inc, GE Healthcare, Beckman colter Inc, Beckton Dickinson and company, Stem Cell Technologies, Stryker Corporation, Medtronic’s plc, Miltenyi Biotec, Celgene Corporation, Nanostring Technologies Inc, and Agilent Technology Inc. GE Healthcare has the major market share in the single cell market as compared to rest of the companies.